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Cost-effectiveness of low-salt diet for 
lowering blood pressure in the Hong 
Kong Chinese population
Key Messages
1. A low-salt diet lowers blood 
pressure, is cost-effective and 
well accepted by patients, so 
hypertensive patients should be 
encouraged to reduce their salt 
intake.
2. Most hypertensive patients 
are likely to need more than 
one antihypertensive drug in 
combination with a low-salt 
diet.
3. For the general population, the 
strategy should be to maintain 
an ideal body weight and 
recommended salt intake.
Hong Kong Med J 2007;13(Suppl 4):S32-6
Introduction
Hypertension affects one in 10 adults in Hong Kong1 and is a risk factor for 
coronary heart disease and strokes. One of the environmental factors that may 
promote the development of hypertension is a high-salt intake. The Intersalt 
project2 was a study of over 10 000 subjects from 52 centres in different 
countries and showed a relationship between sodium and blood pressure 
levels. In a dietary and nutritional survey of British adults, a difference in 
sodium intake of 100 mmol was associated with a blood pressure difference 
of 5 mm Hg/1 mm Hg in men and 7 mm Hg/4 mm Hg in women.3 Many 
studies have failed to show a relationship between sodium intake and blood 
pressure because of regression dilution bias and short study durations. Studies 
that involved salt restriction for more than 4 weeks showed a blood pressure 
reduction as predicted.4-6
 In Caucasians, the relationship between blood pressure and sodium intake 
is still questioned. The food industry prefers to ignore the evidence. Three 
quarters of dietary sodium in the western diet is hidden in processed food. A 
substantial reduction in sodium intake would require the purchase of expensive 
food items or a change in food industry practices. In Chinese, there is a clearer 
relationship between blood pressure and sodium intake.2 Moreover, there is a 
steep rise in blood pressure with age, associated with a high-sodium intake. 
In Hong Kong, the prevalence of hypertension rises from below 1% in people 
under 35 years to 27% in men and 36% in women over 65.1 Dietary salt intake 
in Hong Kong is high, the mean being 203 mmol Na/day.1 Local studies show 
that blood pressure is related to sodium intake.7 A high-salt intake may be a risk 
factor for stroke independent of blood pressure. The benefits are much larger if 
a significant reduction in blood pressure can be achieved. Reducing salt intake 
by several mm Hg may be sufficient to enable reduction or withdrawal of anti-
hypertensive medications in patients with mild hypertension. Although a low-
salt diet is safe and cheap, its cost-effectiveness needs to be established, as 
there is demand on dieticians’ time and a change in spending on food. Our 
hypothesis was: because blood pressure levels are related to sodium intake, a 
low-salt diet might be efficacious and cost-effective in patients with borderline-
to-mild hypertension.
Methods
This study was conducted from October 1998 to September 2000. The faculty 
ethics committee approved the protocol.
Relationship between sodium intake and blood pressure in normal 
adults
Adults between the ages of 18 and 75 years inclusive who were not current 
hospital patients were recruited. They were asked to come to the Queen Mary 
Hospital, were questioned about their medical and dietary histories and had 
their height, weight, waist-hip ratio, body fat, dietary patterns, exercise and 
alcohol habits, blood pressure, 24-hour urinary electrolytes, plasma electrolytes 
assessed. High-sodium food items regularly consumed by these subjects were 
identified.
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Randomised controlled trial of sodium restriction in 
the treatment of mild essential hypertension
A total of 93 patients with mild-to-moderate hypertension 
(pre-treatment diastolic blood pressure of 90-110 mm Hg) 
attending the hypertension out-patient clinic were recruited 
and gave informed consent. All patients underwent a 4-
week placebo run-in phase; 74 patients were randomised to 
conventional treatment (hydrochlorothiazide 25 mg daily or 
metoprolol 100 mg daily) or a low-sodium (80 mmol/day) 
diet for 6 months. At baseline, 3 months, and 6 months, 3-
day food diaries were completed. The patients were seen by 
a dietician and completed food frequency questionnaires. 
The data yielded by these were used in a nutrient analysis 
(Nutrient Analysis System, Nutritionist IV; N-Squared 
Computing, First DataBank Division, San Bruno [CA], 
US). Those allocated to conventional treatment received 
conventional lifestyle advice from a doctor and a nurse, and 
were given drugs needed to achieve a target seated diastolic 
blood pressure of <90 mm Hg. Those allocated to the low-
sodium diet received special instructions from a dietician 
regarding a low-sodium (80 mmol/day) intake. They were 
then seen at monthly intervals, when their food diaries were 
reviewed to monitor their dietary intake and compliance, 
and the dietary advice reinforced. Blood pressure and 
24-hour urine sodium measurements were performed at 
baseline, 3 months, and 6 months. If the blood pressure 
exceeded 160/90 mm Hg after 3 months of a low-sodium 
diet, antihypertensive medication was started. Patients on 
the low-sodium diet were asked to rate the diet and their 
quality-of-life was assessed by a questionnaire (WHOQOL-
BREF [HK]).
Cost-effectiveness of salt reduction vs drug therapy
Cost-effectiveness ratios (cost per mm Hg fall in diastolic 
blood pressure) were calculated for the low-salt diet and 
conventional treatment. The costs included health service 
costs and patient costs. Health service costs included the 
dietician’s and doctor’s time, costs of drugs, and laboratory 
tests. Patient costs include changes in the cost of food, 
food supplements, and lifestyle, as well as the costs of 
extra visits to see the dietician. To test the robustness of 
the cost difference between diet and drugs, we performed a 
sensitivity analysis, varying the cost of drugs and food, the 
dietician’s time, and the degree of blood pressure lowering.
Results
The relationship between sodium intake and blood 
pressure in normal adults
Altogether 190 adults were studied. Of these, 151 were 
normotensive and 39 were hypertensive. Systolic blood 
pressure correlated with age (r=0.52, P<0.001) [Fig 1a] and 
various indices of obesity, including body mass (r=0.24, 
P=0.001), body mass index (r=0.36, P<0.001), waist-hip 
ratio (r=0.49, P<0.001), and waist circumference (r=0.44, 
P<0.001). Diastolic blood pressure correlated with age 
(r=0.35, P<0.001), sex (r=0.27, P<0.001), and various 
indices of obesity, including body mass (r=0.39, P<0.001), 
body mass index (r=0.39, P<0.001), waist-hip ratio (r=0.53, 
P<0.001), and waist circumference (r=0.53, P<0.001) [Fig 
1b]. The 24-hour urinary sodium excretion did not correlate 
significantly with the systolic and diastolic blood pressures 
but did correlate with the 24-hour ambulatory systolic blood 
pressure (r=0.65, P<0.001) in 23 subjects who underwent 
ambulatory blood pressure monitoring (Fig 1c).
Randomised controlled trial of sodium restriction in 
the treatment of mild essential hypertension
Thirty-six patients were randomised to drug treatment 
(with hydrochlorothiazide 25 mg daily [n=19], metoprolol 
100 mg daily [n=15], or perindopril [n=2]) and 38 to a low-
sodium diet. Their baseline characteristics (mean±SD) are 
shown in Table 1.
 In the low-sodium diet group, there was a significant 
decrease in sodium intake (54±11 mmol/day), as assessed 
by the nutrient analysis (Table 2). Sodium intake assessed 
by the nutrient analysis correlated with 24-hour urinary 
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Fig 1. Relationship between sodium intake and blood pressure in normal adults
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sodium excretion (r=0.3, P<0.001). Using dietary recall, 
foods with a high-sodium content were identified (Table 3). 
In the diet group, there was a significant decrease in body 
mass and body fat (2.1±0.4%; Table 4). After five visits, 14 
patients in the diet group required drug treatment to control 
their blood pressure. Changes in blood pressure, heart rate, 
urinary sodium and potassium excretion, body mass, and 
left ventricular mass index are shown in Table 4.
 There was a significant decrease in ambulatory systolic 
and diastolic blood pressure in the drug (16±3 mm Hg and 
9±2 mm Hg) and diet group (9±2 mm Hg and 6±1 mm Hg).
The decreases in ambulatory blood pressure were 
significantly larger in the drug group compared to the diet 
group. In the diet group, the decrease in sodium intake 
correlated with the decrease in diastolic blood pressure 
(r=0.44, P=0.02; Fig 2) but not with systolic blood pressure 
(r=0.35, P=0.1).
Cost-effectiveness of salt reduction vs drug therapy
The health service costs and the patient costs for diet and 
drug therapy are listed in Table 5. There were 32 subjects in 
the diet group and 29 in the drug group with economic data 
available for analysis.
 The costs of medications were $30.4±9.3 and 
$157.7±28.1 in the diet and drug groups, respectively 
(P<0.001). Health service costs per subject were 
$764.5±13.9 in the diet group and $736.1±29.5 in the 
drug group. Total costs per subject were $591.6±163.4 
in the diet group and $774.8±75.0 in the drug group. 
The cost-effectiveness ratios for diet and drug therapy 
were $103.1±56.7 and $69.6±39.6 per mm Hg decrease 
in diastolic blood pressure. These were not significantly 
different. A sensitivity analysis showed that the cost-
effectiveness ratio depends on the blood pressure reduction 
and the food costs, but is insensitive to dietician’s time and 
drug costs. Overall, there were no significant changes in 
quality of life in terms of WHOQOL-BREF (HK) scores 
associated with either form of therapy. In the diet group, 
94% found the low-salt diet acceptable. Subjects in the diet 
group were willing to pay more for the diet ($479.0±118.1 
vs 430.4±75.4), although this finding was not statistically 
significant.
Discussion
Our study of nearly 200 subjects recruited from the general 
Baseline characteristics Mean±SD
Diet group Drug group
No. of subjects 38 36
% of male 50 42
Age (years) 45±12 41±9
Weight (kg) 69.5±12.9 67.8±12.6
Body mass index (kg/m2) 26.1±6.7 25.6±6.1
Waist circumference (cm) 89.4±10.9 85.2±11.2
24-h Na+ (mmol/day) 194.6±84.7 192.7±73.8
Systolic blood pressure (mm Hg) 142±12 142±11
Diastolic blood pressure (mm Hg) 94±8 96±6
Heart rate (beats per minute) 70±8 72±9
Table 1. Baseline characteristics of randomised subjects
Sodium intake (mmol/day)
Mean±SD
Baseline 3 Months 6 Months
No. of subjects 74 63 62
Diet group 178.2±12.2 122.9±10.7* 124.6±10.0*
Drug group 168.3±8.7 158.1±9.5 153.9±9.0
Table 2. Sodium intake in the diet and drug groups
* P<0.05 vs baseline and drug group
Food Typical portion 
(g)
Sodium content 
(mmol)
Ham 40 23.1
Dim sum 100 26.7
Marinated spare ribs 80 23.1
Chinese barbecue pork 80 36.9
Instant noodles 100 49.6
Fish balls 60 17.4
Sausages 34 19.1
Fried rice 180 23.6
Preserved vegetables 40 37.7-140.6
Luncheon meat 28 16.2
Table 3. Commonly eaten foods that are high in sodium 
content
Measurement Diet group
Mean±SE
Drug group
Mean±SE
Baseline 3 Months 6 Months Baseline 3 Months 6 Months
No. of subjects 38 33 31 36 31 31
Systolic blood pressure (mm Hg) 142±2.1 141±2.8 134±2.2* 141±2.0 129±2.5*† 124±2.5*†
Diastolic blood pressure (mm Hg) 95±1.3 91±1.6* 88±1.3* 95±1.0 86±1.7*† 84±1.8*†
Heart rate (beats per minute) 69±1.2 68±1.6 68±1.5 71±1.5 67±1.5 69±1.6
24-h Na+ (mmol/day) 190.7±14.5 154.2±13.6* 201.2±15.9 200.4±13.6 164.0±11.1* 179.7±13.3
24-h K+ (mmol/day) 46.5±3.0 47.9±3.0 55.7±3.9* 54.2±4.7 49.5±3.8 49.3±4.0
Body mass (kg) 67.5±2.1 66.0±2.0 65.6±2.0* 68.8±2.4 67.3±2.2 67.2±2.2
Left ventricular mass index (g/m2) 128.7±4.8 - 124.9±4.3 129.3±5.6 - 123.6±4.8
Table 4. Changes in measurements
* P<0.05 vs baseline
† P<0.05 diet vs drug groups
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population showed that the correlation between sodium 
excretion and blood pressure is weak. This correlation is 
stronger among hypertensive subjects. This is an expected 
finding because not everyone in the general population 
who has a high-salt intake will develop hypertension. What 
clearly emerged from our study was the strong relationship 
between blood pressure and obesity, especially the waist 
circumference. This is consistent with clinical studies 
showing that weight control is by far the most effective 
non-pharmacological means of lowering blood pressure.
 In our randomised controlled trial of a low-sodium 
diet, we showed that the diet achieved a reduced sodium 
intake and urinary sodium excretion and that there were 
significant reductions in both systolic and diastolic blood 
pressure. Moreover, the reduction in diastolic blood pressure 
correlated with the reduction in sodium intake. Nonetheless, 
although blood pressure levels decreased significantly in 
both groups, there was a much greater decrease in blood 
pressure levels in the group allocated to drug treatment. 
Most patients randomised to the low-sodium diet group 
eventually required drug treatment to bring their blood 
pressure down to the target level. Non-pharmacological 
treatment can still enhance the effects of drug therapy, 
resulting in a lighter drug regimen and fewer side-effects. A 
diet that is not only low in sodium but also rich in fruit and 
vegetables might be more effective. Moreover, the healthy 
diet and lifestyle approach addresses not only high blood 
pressure but also other cardiovascular risk factors such as 
obesity, glucose tolerance, and dyslipidaemia.
 Our economic analysis found that the low-sodium diet 
and drug therapy were equally cost-effective. We used upper 
and lower 95% confidence limits to test the robustness 
of the cost-effectiveness ratios and found that they were 
mainly sensitive to the degree of blood pressure reduction 
and change in the cost of food. Due to the limited size of our 
study and the entry criteria for a clinical trial, our estimate of 
the effect size, ie the reduction in blood pressure, is subject 
to error. Caution must be exercised if extrapolating our 
findings to the community and generalising our conclusions. 
Nevertheless, our analysis of the costs of the low-sodium 
diet showed that savings in drug costs offset the cost of the 
dietician’s time. It is sometimes argued that special diets 
are less affordable, but patients in the diet group reported a 
decrease in the costs of food. This suggests that for the Hong 
Kong Chinese population, a low-sodium diet does not cost 
more. Moreover, the dietary restrictions did not decrease 
quality of life and nearly all patients in the low-sodium diet 
group found the regimen acceptable.
Conclusions
As a reduction in blood pressure is related to a reduction 
in sodium intake, hypertensive patients able to reduce their 
sodium intake should be able to lower their blood pressure. 
A low-sodium diet reduces blood pressure to a lesser extent 
than antihypertensive drugs but this reduction may be 
sufficient for patients with mild hypertension. In patients 
with more severe hypertension, dietary sodium reduction 
is a safe, cost-effective complement to drug therapy. The 
low-sodium diet should be part of a calorie-controlled diet 
* Cost-effectiveness ratios were calculated for each individual
Mean±SD P value
Low-salt diet Drug therapy
No. of subjects 32 29 -
Dietician’s time (3 visits, $/subject) 146.3±8.3 - -
Doctor’s time (2 visits, $/subject) 107.8±6.3 98.4±6.3 -
Cost of drugs ($/subject) 30.4±9.3 157.7±28.1 <0.001
Cost of laboratory test (renal function test, $/subject) 480 480 -
Health service cost ($/subject) 764.5±13.9 736.1±29.5 0.39
Change in cost of food ($/subject) -357.3±152.0 -137.4±97.5 -
Cost of food supplements ($/subject) 47.8±37.7 - -
Cost of lifestyle changes ($/subject) 25.0±19.6 53.1±53.1 -
Travelling costs ($/subject) 111.7±11.8 123.0±15.0 -
Patients’ costs ($/subject) -172.8±162.8 38.7±85.4 0.26
Total cost ($/subject) 591.6±163.4 774.8±75.0 0.31
Fall in diastolic blood pressure (mm Hg) 7.4±1.4 11.1±1.9 0.12
Cost-effectiveness ratio ($/mm Hg fall in diastolic blood pressure)* 103.1±56.7 69.6±39.6 0.64
Table 5. Cost-effectiveness of low-salt diet versus drug therapy
Fig 2. Correlation of ambulatory blood pressure and sodium 
intake
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rich in fruits and vegetables. In terms of public health, a 
healthy diet and lifestyle may reduce the prevalence of 
hypertension.
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